- Home
- INKT vs ELBM Comparison
INKT vs ELBM Comparison
Compare INKT & ELBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INKT | ELBM |
|---|---|---|
| Founded | 2017 | 2011 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Industrial Machinery/Components |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 70.6M | 62.2M |
| IPO Year | 2021 | 2022 |
Fundamental Metrics
Financial Performance| Metric | INKT | ELBM |
|---|---|---|
| Price | $12.80 | $0.70 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $35.00 | $2.15 |
| AVG Volume (30 Days) | 36.3K | ★ 898.2K |
| Earning Date | 05-15-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $28.71 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.80 | $0.50 |
| 52 Week High | $76.00 | $8.70 |
Technical Indicators
Market Signals| Indicator | INKT | ELBM |
|---|---|---|
| Relative Strength Index (RSI) | 60.04 | 60.29 |
| Support Level | $10.79 | $0.56 |
| Resistance Level | $15.67 | $0.72 |
| Average True Range (ATR) | 1.03 | 0.04 |
| MACD | 0.23 | 0.01 |
| Stochastic Oscillator | 80.68 | 71.51 |
Price Performance
Historical ComparisonAbout INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development and manufacturing of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. iNKT cells offer distinct therapeutic advantages as a platform for allogeneic therapy in that the cells naturally home to tissues, aid clearance of tumors and infected cells, and suppress graft-versus-host-disease. Its product candidate, agenT-797, is an off-the-shelf, allogeneic, native iNKT cell therapy. It operates its business in single segment.
About ELBM Electra Battery Materials Corporation
Electra Battery Materials Corp is building North America's fully integrated, localized, and environmentally sustainable battery materials park. Electra Battery Materials is an integral part of the North American battery supply chain, providing low-carbon, sustainable, and traceable raw materials for the region's fast growing electric vehicle industry. The Company's operating segments are Refinery, Exploration and Evaluation, Corporate and Other.